NextCure
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.About NXTC
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines.
CEOMichael S. Richman
CEOMichael S. Richman
Employees43
Employees43
HeadquartersBeltsville, Maryland
HeadquartersBeltsville, Maryland
Founded2015
Founded2015
Employees43
Employees43
NXTC Key Statistics
Market cap12.69M
Market cap12.69M
Price-Earnings ratio-0.25
Price-Earnings ratio-0.25
Dividend yield—
Dividend yield—
Average volume193.05K
Average volume193.05K
High today$0.4699
High today$0.4699
Low today$0.434
Low today$0.434
Open price$0.434
Open price$0.434
Volume42.32K
Volume42.32K
52 Week high$1.82
52 Week high$1.82
52 Week low$0.224
52 Week low$0.224
NXTC News
TipRanks 4d
NextCure reports Q1 EPS (39c), consensus (40c)“With our LNCB74 antibody-drug conjugate program completing cohort 2 in April 2025, we are progressing as planned through the dose escalation portion of the Pha...
People also own
Based on the portfolios of people who own NXTC. This list is generated using Robinhood data, and it’s not a recommendation.